nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfacalcidol—VDR—periosteum—bone cancer	0.0822	0.185	CbGeAlD
Alfacalcidol—VDR—vertebral column—bone cancer	0.0681	0.153	CbGeAlD
Alfacalcidol—CYP27B1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0676	0.127	CbGpPWpGaD
Alfacalcidol—VDR—leg—bone cancer	0.0655	0.148	CbGeAlD
Alfacalcidol—VDR—forelimb—bone cancer	0.065	0.146	CbGeAlD
Alfacalcidol—VDR—hindlimb—bone cancer	0.0585	0.132	CbGeAlD
Alfacalcidol—VDR—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.0504	0.0951	CbGpPWpGaD
Alfacalcidol—VDR—appendage—bone cancer	0.0502	0.113	CbGeAlD
Alfacalcidol—VDR—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0453	0.0854	CbGpPWpGaD
Alfacalcidol—CYP27B1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0365	0.0688	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—CYP4V2—bone cancer	0.0291	0.0548	CbGpPWpGaD
Alfacalcidol—VDR—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.0265	0.0499	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.026	0.049	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors—NR1I2—bone cancer	0.0238	0.0449	CbGpPWpGaD
Alfacalcidol—CYP27B1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0213	0.0402	CbGpPWpGaD
Alfacalcidol—GC—spinal cord—bone cancer	0.0207	0.0466	CbGeAlD
Alfacalcidol—VDR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0188	0.0355	CbGpPWpGaD
Alfacalcidol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0152	0.0286	CbGpPWpGaD
Alfacalcidol—VDR—connective tissue—bone cancer	0.0143	0.0323	CbGeAlD
Alfacalcidol—CYP27B1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.0135	0.0255	CbGpPWpGaD
Alfacalcidol—CYP27B1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.0134	0.0252	CbGpPWpGaD
Alfacalcidol—CYP27B1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.011	0.0207	CbGpPWpGaD
Alfacalcidol—VDR—Ovarian Infertility Genes—CDK4—bone cancer	0.00989	0.0186	CbGpPWpGaD
Alfacalcidol—VDR—tendon—bone cancer	0.00985	0.0222	CbGeAlD
Alfacalcidol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.0098	0.0185	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—ZNF77—bone cancer	0.0096	0.0181	CbGpPWpGaD
Alfacalcidol—VDR—bone marrow—bone cancer	0.00954	0.0215	CbGeAlD
Alfacalcidol—Paricalcitol—CYP3A4—bone cancer	0.00753	0.294	CrCbGaD
Alfacalcidol—Calcitriol—CYP3A4—bone cancer	0.00753	0.294	CrCbGaD
Alfacalcidol—Ergocalciferol—CYP3A4—bone cancer	0.00602	0.235	CrCbGaD
Alfacalcidol—CYP27B1—Biological oxidations—CYP3A4—bone cancer	0.00583	0.011	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—CYP3A4—bone cancer	0.00575	0.0108	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—NDUFA12—bone cancer	0.00556	0.0105	CbGpPWpGaD
Alfacalcidol—VDR—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.00539	0.0102	CbGpPWpGaD
Alfacalcidol—CYP27B1—Biological oxidations—GSTP1—bone cancer	0.00499	0.0094	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metapathway biotransformation—GSTP1—bone cancer	0.00492	0.00927	CbGpPWpGaD
Alfacalcidol—VDR—Validated transcriptional targets of TAp63 isoforms—MDM2—bone cancer	0.00482	0.00909	CbGpPWpGaD
Alfacalcidol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.0047	0.00887	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—ZNF77—bone cancer	0.00462	0.00871	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—NT5C3A—bone cancer	0.00461	0.00869	CbGpPWpGaD
Alfacalcidol—Cholecalciferol—CYP3A4—bone cancer	0.00456	0.178	CrCbGaD
Alfacalcidol—CYP27B1—Metabolism—NDUFA12—bone cancer	0.00349	0.00659	CbGpPWpGaD
Alfacalcidol—VDR—Generic Transcription Pathway—NR1I2—bone cancer	0.00325	0.00612	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—MET—bone cancer	0.00304	0.00572	CbGpPWpGaD
Alfacalcidol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.00303	0.00572	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—NT5C3A—bone cancer	0.0029	0.00546	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—RB1—bone cancer	0.00264	0.00498	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—MMP2—bone cancer	0.00253	0.00478	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—FUS—bone cancer	0.00226	0.00425	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—MDM2—bone cancer	0.00225	0.00424	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—ENO2—bone cancer	0.00202	0.00381	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—JUN—bone cancer	0.00196	0.00369	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—DHFR—bone cancer	0.00187	0.00353	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—GNA11—bone cancer	0.00175	0.0033	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—CYP3A4—bone cancer	0.00159	0.00299	CbGpPWpGaD
Alfacalcidol—GC—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.00158	0.00298	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—NR1I2—bone cancer	0.00156	0.00295	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—EGFR—bone cancer	0.00154	0.0029	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—GSTP1—bone cancer	0.00136	0.00256	CbGpPWpGaD
Alfacalcidol—VDR—Direct p53 effectors—TP53—bone cancer	0.00129	0.00244	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—ENO2—bone cancer	0.00127	0.00239	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—DHFR—bone cancer	0.00118	0.00222	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—EIF2S1—bone cancer	0.00115	0.00218	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—GNA11—bone cancer	0.0011	0.00207	CbGpPWpGaD
Alfacalcidol—VDR—Gene Expression—EZH2—bone cancer	0.001	0.00189	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—CYP3A4—bone cancer	0.000997	0.00188	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000992	0.00187	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—GSTP1—bone cancer	0.000853	0.00161	CbGpPWpGaD
Alfacalcidol—GC—Metabolism—PTGS2—bone cancer	0.000703	0.00133	CbGpPWpGaD
Alfacalcidol—CYP27B1—Metabolism—PTGS2—bone cancer	0.000442	0.000833	CbGpPWpGaD
